Dianthus Therapeutics, Inc. /DE/ (DNTH) — Institutional Holders, Q2 2026

272 institutional investment managers reported a DNTH position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $6.4B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

DNTH in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

60

Added to

116

Trimmed

69

Sold out

32

Biggest buyers

  1. T. Rowe Price Investment ManagementAdded · +2,596,274 sh+$253.1M
  2. PRICE T ROWE ASSOCIATESAdded · +1,367,998 sh+$133.4M
  3. STATE STREETAdded · +958,527 sh+$93.4M
  4. BlackRockAdded · +948,119 sh+$92.4M
  5. WELLINGTON MANAGEMENT GROUP LLPAdded · +634,099 sh+$61.8M

Biggest sellers

  1. RA CAPITAL MANAGEMENT, L.P.Sold out · -2,611,733 sh-$254.6M
  2. FARALLON CAPITAL MANAGEMENTSold out · -836,000 sh-$81.5M
  3. Point72 Asset Management, L.P.Sold out · -643,599 sh-$62.7M
  4. CITADEL ADVISORSTrimmed · -635,572 sh-$62.0M
  5. Catalio Capital ManagementTrimmed · -527,367 sh-$51.4M

DNTH 13F holders ranked 1–100 of 272

Institutional investors reporting a position in Dianthus Therapeutics, Inc. /DE/ on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
FMR#1 · 8,199,893 sh$799.3M+5.6%
BlackRock#2 · 4,123,822 sh$402.0M+29.9%
T. Rowe Price Investment Management#3 · 3,888,456 sh$379.0M+200.9%
WELLINGTON MANAGEMENT GROUP LLP#4 · 3,229,882 sh$314.8M+24.4%
Fairmount Funds Management#5 · 2,537,191 sh$247.3M0.0%
PRICE T ROWE ASSOCIATES#6 · 2,514,946 sh$245.2M+119.3%
STATE STREET#7 · 2,357,440 sh$229.8M+68.5%
VANGUARD CAPITAL MANAGEMENT#8 · 2,159,568 sh$210.5M+6.3%
Avidity Partners Management#9 · 2,104,184 sh$205.1M0.0%
Octagon Capital Advisors#10 · 1,841,667 sh$179.5M-5.4%
TCG Crossover Management#11 · 1,676,624 sh$163.4M0.0%
FRED ALGER MANAGEMENT#12 · 1,302,493 sh$127.0M+12.1%
GEODE CAPITAL MANAGEMENT#13 · 1,258,502 sh$122.7M+37.4%
VR Adviser#14 · 1,180,000 sh$115.0M0.0%
UBS Group AG#15 · 1,140,260 sh$111.2M+45.9%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#16 · 1,125,313 sh$109.7M+10.3%
JENNISON ASSOCIATES#17 · 1,021,763 sh$99.6M+110.6%
Polar Capital Plc#18 · 1,018,726 sh$99.3M-5.3%
CITADEL ADVISORS#19 · 974,911 sh$95.0M-39.5%
FRANKLIN RESOURCES#20 · 968,983 sh$94.5M+0.1%
BAKER BROS. ADVISORS#21 · 852,164 sh$83.1M0.0%
Logos Global Management#22 · 800,000 sh$78.0M+100.0%
Cormorant Asset Management#23 · 750,000 sh$73.1M-21.1%
ALLIANCEBERNSTEIN L.P.#24 · 834,150 sh$70.0M-9.9%
BRAIDWELL#25 · 594,562 sh$58.0M-33.9%
VANGUARD PORTFOLIO MANAGEMENT#26 · 570,115 sh$55.6M+63.2%
AMERIPRISE FINANCIAL#27 · 531,999 sh$51.9M+48.4%
Woodline Partners#28 · 500,548 sh$48.8M+15.5%
BARCLAYS PLC#29 · 431,753 sh$42.1M+13.7%
LORD, ABBETT#30 · 422,185 sh$41.2M+41.1%
MPM BioImpact#31 · 420,002 sh$40.9M-0.9%
NORTHERN#32 · 411,791 sh$40.1M+35.6%
Affinity Asset Advisors#33 · 400,000 sh$39.0M+14.3%
SILVERARC CAPITAL MANAGEMENT#34 · 390,000 sh$38.0M-40.4%
GOLDMAN SACHS GROUP#35 · 382,161 sh$37.3M-30.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT#36 · 365,963 sh$35.7M+19.8%
Bain Capital Life Sciences Investors#37 · 362,470 sh$35.3M0.0%
Spruce Street Capital#38 · 354,816 sh$34.6M-4.9%
Vivo Capital#39 · 353,998 sh$34.5M0.0%
DIMENSIONAL FUND ADVISORS#40 · 321,503 sh$31.3M-1.2%
WESTFIELD CAPITAL MANAGEMENT#41 · 314,914 sh$30.7MNew
VANGUARD FIDUCIARY#42 · 302,482 sh$29.5M+21.1%
DRIEHAUS CAPITAL MANAGEMENT#43 · 295,266 sh$28.8M-6.9%
First Turn Management#44 · 285,771 sh$27.9M+29.4%
Assenagon Asset Management S.A.#45 · 280,649 sh$27.4MNew
TANG CAPITAL MANAGEMENT#46 · 264,692 sh$25.8M0.0%
Artisan Partners Limited Partnership#47 · 258,269 sh$25.2M-32.4%
BANK OF AMERICA#48 · 256,833 sh$25.0M+36.0%
Bank of New York Mellon#49 · 256,393 sh$25.0M+36.1%
RTW INVESTMENTS#50 · 248,063 sh$24.2M0.0%
EMERALD ADVISERS#51 · 247,805 sh$24.2MNew
Pictet Asset Management Holding SA#52 · 247,295 sh$24.1M+4922.2%
TD ASSET MANAGEMENT#53 · 225,334 sh$22.0M+93.3%
EVENTIDE ASSET MANAGEMENT#54 · 225,261 sh$22.0M0.0%
LMR Partners LLP#55 · 223,995 sh$21.8M+92.4%
Candriam S.C.A.#56 · 204,214 sh$19.9M-4.4%
StemPoint Capital#57 · 200,851 sh$19.6M+134.9%
Qube Research & Technologies Ltd#58 · 196,924 sh$19.2M+548.8%
SAMLYN CAPITAL#59 · 196,326 sh$19.1M-54.5%
Nicholas Investment Partners#60 · 186,769 sh$18.2M+264.4%
ADAGE CAPITAL PARTNERS GP, L.L.C.#61 · 185,000 sh$18.0M+15.6%
Ensign Peak Advisors#62 · 174,187 sh$17.0M-14.8%
TimesSquare Capital Management#63 · 166,357 sh$16.2MNew
Atika Capital Management#64 · 165,000 sh$16.1M+28.1%
Artia Global Partners#65 · 162,990 sh$15.9M0.0%
BALYASNY ASSET MANAGEMENT L.P.#66 · 162,005 sh$15.8M-65.8%
Neuberger Berman Group#67 · 157,574 sh$15.4M+166.7%
Alyeska Investment Group, L.P.#68 · 150,592 sh$14.7M+188.2%
Russell Investments Group, Ltd.#69 · 143,431 sh$14.0M+11.1%
Eagle Health Investments#70 · 131,344 sh$12.8MNew
EMERALD MUTUAL FUND ADVISERS#71 · 131,018 sh$12.8MNew
MARSHALL WACE, LLP#72 · 128,743 sh$12.5M-62.3%
PFM Health Sciences#73 · 121,222 sh$11.8M-29.6%
Tri Locum Partners#74 · 120,712 sh$11.8M-17.1%
Nuveen#75 · 119,460 sh$11.6M-45.1%
ORBIMED ADVISORS#76 · 115,000 sh$11.2MNew
Patient Square Capital#77 · 108,000 sh$10.5M+15.0%
TWO SIGMA INVESTMENTS#78 · 107,455 sh$10.5MNew
MORGAN STANLEY#79 · 106,376 sh$10.4M+9.2%
SEVEN GRAND MANAGERS#80 · 100,000 sh$9.7M0.0%
FIRST ADVISORS#81 · 94,152 sh$9.2MNew
SEI INVESTMENTS#82 · 92,280 sh$9.0M+0.1%
MILLENNIUM MANAGEMENT#83 · 91,838 sh$9.0M-64.9%
VICTORY CAPITAL MANAGEMENT#84 · 88,315 sh$8.6M+463.9%
AMERICAN CENTURY COMPANIES#85 · 87,860 sh$8.6M+11.1%
Rhenman & Partners Asset Management AB#86 · 86,127 sh$8.4M+5.5%
Invesco Ltd.#87 · 85,603 sh$8.3M-34.5%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#88 · 75,396 sh$7.3M+24.8%
MOODY ALDRICH PARTNERS#89 · 74,552 sh$7.3M-9.2%
Swiss National Bank#90 · 73,800 sh$7.2M+7.0%
DEUTSCHE BANK AG\#91 · 69,756 sh$6.8M+121.7%
MERCER GLOBAL ADVISORS#92 · 65,683 sh$6.4MNew
LPL Financial#93 · 65,295 sh$6.4M+59.9%
Seven Fleet Capital Management#94 · 64,723 sh$6.3M+19.3%
SummitTX Capital, L.P.#95 · 63,866 sh$6.2M-36.2%
MANUFACTURERS LIFE INSURANCE COMPANY, THE#96 · 62,829 sh$6.1M-3.7%
NEW YORK STATE COMMON RETIREMENT FUND#97 · 60,048 sh$5.9M+25.2%
Sio Capital Management#98 · 59,254 sh$5.8M-84.0%
RHUMBLINE ADVISERS#99 · 58,521 sh$5.7M+29.5%
Jones Hill Capital#100 · 57,100 sh$5.6MNew

Funds that sold out of DNTH in Q2 2026 (32)

Held DNTH at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held DNTH in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
RA CAPITAL MANAGEMENT, L.P.2,611,733 sh$219.2M
FARALLON CAPITAL MANAGEMENT836,000 sh$70.2M
Point72 Asset Management, L.P.643,599 sh$54.0M
Freestone Grove Partners239,943 sh$20.1M
Integral Health Asset Management150,000 sh$12.6M
ExodusPoint Capital Management85,530 sh$7.2M
Nantahala Capital Management67,282 sh$5.6M
ADAR1 Capital Management55,000 sh$4.6M
Evergreen Quality Fund GP, Ltd.50,000 sh$4.2M
Squarepoint Ops38,738 sh$3.3M
DV Trading26,551 sh$2.2M
Darwin Global Management, Ltd.17,357 sh$1.5M
XTX Topco Ltd13,047 sh$1.1M
Lisanti Capital Growth12,410 sh$1.0M
DIADEMA PARTNERS10,000 sh$839.2K
J. Goldman7,716 sh$647.5K
DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.7,600 sh$637.8K
Polymer Capital Management (US)7,339 sh$615.9K
Fieldview Capital Management5,973 sh$501.3K
Cannon Global Investment Management5,100 sh$428.0K
TWINBEECH CAPITAL4,831 sh$405.4K
RWC Asset Management LLP4,646 sh$389.9K
NOMURA3,837 sh$322.0K
PEAK62,925 sh$245.5K
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.2,540 sh$213.2K
49 WEALTH MANAGEMENT2,513 sh$210.9K
Chung Wu Investment Group2,300 sh$193.0K
Caitong International Asset Management , Ltd1,476 sh$123.9K
Advisory Services Network45 sh$3.8K
MAI Capital Management18 sh$1.5K
Ameritas Advisory Services11 sh$923.00
Root Financial Partners3 sh$252.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.